Pulmonx (LUNG) Retained Earnings (2019 - 2025)
Pulmonx's (LUNG) quarterly Retained Earnings came in at -$521.6 million in Q4 2025, down 11.55% year-over-year from -$589.7 million in Q4 2024, and down 2.04% quarter-over-quarter from -$511.1 million in Q3 2025.
Analysis
Pulmonx (LUNG) Retained Earnings (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Retained Earnings for 7 consecutive years, with -$521.6 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Retained Earnings fell 11.55% year-over-year to -$521.6 million in Q4 2025; TTM through Dec 2025 was -$521.6 million, a 11.55% decrease from a year earlier, with the FY2025 full-year figure at -$521.6 million, down 11.55% from the prior year.
- Retained Earnings was -$521.6 million for Q4 2025 at Pulmonx, down from -$511.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$254.8 million in Q1 2021 and troughed at -$521.6 million in Q4 2025.
- A 5-year average of -$388.2 million and a median of -$389.8 million in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings slipped 20.7% in 2022 and slipped 11.55% in 2025, its largest moves.
- Over 5 years, Retained Earnings stood at -$291.4 million in 2021, then fell by 20.22% to -$350.3 million in 2022, then declined by 17.37% to -$411.2 million in 2023, then slipped by 13.72% to -$467.6 million in 2024, then fell by 11.55% to -$521.6 million in 2025.
- The last three Retained Earnings figures came in at -$521.6 million (Q4 2025), -$511.1 million (Q3 2025), and -$497.2 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 33.19 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.82 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 7.82 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 14.86 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.58 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.88 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Pulmonx | 75.94 Mn | 6.19 Mn | - | -521.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -521.56 Mn |
| Sep 30, 2025 | -511.13 Mn |
| Jun 30, 2025 | -497.20 Mn |
| Mar 31, 2025 | -482.00 Mn |
| Dec 31, 2024 | -467.56 Mn |
| Sep 30, 2024 | -454.40 Mn |
| Jun 30, 2024 | -440.24 Mn |
| Mar 31, 2024 | -424.91 Mn |
| Dec 31, 2023 | -411.16 Mn |
| Sep 30, 2023 | -397.30 Mn |
| Jun 30, 2023 | -382.40 Mn |
| Mar 31, 2023 | -366.20 Mn |
| Dec 31, 2022 | -350.32 Mn |
| Sep 30, 2022 | -336.04 Mn |
| Jun 30, 2022 | -321.90 Mn |
| Mar 31, 2022 | -307.22 Mn |
| Dec 31, 2021 | -291.40 Mn |
| Sep 30, 2021 | -278.40 Mn |
| Jun 30, 2021 | -267.20 Mn |
| Mar 31, 2021 | -254.80 Mn |